Literature DB >> 3008491

Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy.

M C Dalakas, G Cunningham.   

Abstract

Review of the clinical and laboratory findings of 39 patients with amyloid polyneuropathy (AP) showed 12 cases to be hereditary and 12 to be associated with plasma cell dyscrasia (PCD). The remaining 15, termed "sporadic" AP, had neuropathy clinically indistinguishable from the other two groups but without a clinicopathologically identified PCD or positive family history. In an attempt to identify the type of amyloid in "sporadic" AP, the immunoreactivity of amyloid deposits was investigated using specific antisera raised against the following different chemical types of amyloid fibril proteins: variable regions of amyloid light chains kappa (A kappa) and lambda (A lambda), amyloid protein AA, and prealbumin. It was found that the amyloid in "sporadic" AP had A lambda antigenic determinants in ten cases, A kappa in one and prealbumin in three; in one case, the A lambda nature of amyloid was confirmed biochemically on the extracted amyloid fibrills. Thus, the most common type of AP in our population appears to be the "sporadic" form. In "sporadic" AP, the amyloid is most commonly of immunoglobulin light chain origin, even in the absence of overt PCD, and it can be rapidly categorized immunocytochemically to determine therapeutic directions or provide genetic guidance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008491     DOI: 10.1007/bf00687040

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.

Authors:  M C Dalakas; W K Engel
Journal:  Trans Am Neurol Assoc       Date:  1979

2.  Chemical evidence for lambda-type amyloid fibril proteins.

Authors:  S Kimura; R Guyer; W D Terry; G G Glenner
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

3.  Amino acid sequence of an amyloid fibril protein of unknown origin.

Authors:  D Ein; S Kimura; W D Terry; J Magnotta; G G Glenner
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

4.  Amyloid fibril protein in familial amyloid polyneuropathy.

Authors:  S Shoji; A Okano
Journal:  Neurology       Date:  1981-02       Impact factor: 9.910

5.  Immunochemical typing of amyloid from tissue biopsies.

Authors:  R P Linke; W B Nathrath
Journal:  Acta Histochem Suppl       Date:  1982

6.  Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies.

Authors:  M C Dalakas; N M Papadopoulos
Journal:  Ann Neurol       Date:  1984-06       Impact factor: 10.422

7.  Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors:  R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

8.  Further structural and antigenic studies of light-chain amyloid proteins.

Authors:  J B Natvig; P Westermark; K Sletten; G Husby; T Michaelsen
Journal:  Scand J Immunol       Date:  1981-07       Impact factor: 3.487

9.  Neuropathy, M components, and amyloid.

Authors:  M D Benson; A S Cohen; K D Brandt; E S Cathcart
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

10.  Systemic amyloid myopathy--light-microscopic and fine-structural study of the skeletal muscles with histochemical and immunohistochemical study of amyloid.

Authors:  K Ii; K Hizawa; S Nunomura; H Morizumi
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

View more
  5 in total

1.  "Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.

Authors:  M Yamada; H Tsukagoshi; J Satoh; S Ishiai; M Nakazato; H Furuya; H Sasaki; Y Sakaki; T Yokota
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

2.  Biochemical and clinical aspects of amyloidosis.

Authors:  D Havlir; L M Tierney
Journal:  West J Med       Date:  1987-07

3.  Proximal weakness of the extremities as main feature of amyloid myopathy.

Authors:  F G Jennekens; J H Wokke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

4.  Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Authors:  K Li; R A Kyle; P J Dyck
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Systemic amyloidosis--three illustrative cases.

Authors:  I F McDowell; D R McCluskey
Journal:  Ulster Med J       Date:  1987-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.